SLAS webinars deliver world-class education and information to your desktop or mobile device. Offered real-time and then made available on demand, SLAS webinars are free to dues-paying members. Choose from a growing inventory of dozens of webinars you can watch when you want, where you want, from the convenience of your Internet browser.
SLAS Webinars are presented by the official Scientific Journals of SLAS.
Search for Webinars
Mitigation and identification of aggregation and nonspecific reactivity interference in high-throughput screeningContains 2 Component(s) Includes a Live Event on 06/07/2018 at 12:00 PM (EDT)
Compound-mediated assay interference and bioassay promiscuity are significant burdens in drug and chemical probe discovery. Pursuing artifacts or poorly tractable, nonselective chemical matter from real and virtual high-throughput screening (HTS) can waste significant scientific resources and can lead to tenuous scientific conclusions when used in subsequent studies.
Using AI and IoT to Accelerate ResearchContains 2 Component(s) Includes a Live Event on 05/08/2018 at 1:00 PM (EDT)
In this webinar, we will explore how new technologies can be used to accelerate scientific research. Join us for an in-depth look at how we can also overcome challenges by practically incorporating new tech into research processes to uncover and decipher hidden confounding variables.
Recommended For You
The SLAS Webinars listed below are based off of your profile interest categories. For more accurate results update your profile listing.
3-Dimensional Assays: What Must Be Done for Setting Up and Validating for Downstream Microplate Reader and Imaging ApplicationsContains 2 Component(s) Recorded On: 09/26/2017
Today’s webinar will focus on the cellular microenvironment and its importance when developing and screening cell-based assays using primary, stem cell, and immortalized cultures in 3D systems.
How AstraZeneca is Revolutionizing Sample Management with Acoustic Tube-based TechnologiesContains 2 Component(s) Recorded On: 12/12/2017
Learn about AstraZeneca’s vision to enhance their sample management capabilities by standardizing on acoustic liquid handling throughout sample storage and screening preparation workflows.
Modular, Fully-Integrated or Collaborative Automation?Contains 2 Component(s) Recorded On: 05/18/2017
The establishment of the AstraZeneca-Medical Research Council UK Centre for Lead Discovery has led to revamping our screening infrastructure to embrace next generation HTS automation. This webinar will recap AZ’s experience: reviewing what works, what scientists like and most importantly what best conforms to the demands of the assay. The presenter will also present AZ’s vision for scalable, modular automation that can be efficiently deployed across customer demand. In conclusion the webinar will summarise the project learnings in the areas of collaborative robotics, remote operation and unforeseen benefits.
On Demand Webinars
Search This List
Search This List
In-house software and processes to support High Content Screening of Primary NeuronsContains 1 Component(s) Recorded On: 02/07/2018
This presentation will focus on the development and implementation of novel in-house software utilities used at Scripps Florida to support the Synaptogenesis neuroscience drug discovery project.
Inline, Label-free Detection Using the Droplet Frequency SensorContains 1 Component(s) Recorded On: 02/07/2018
Inline detectors are extensively used in chemical separations and other life sciences workflows to quantify analytes based on fundamental properties.
Open development from user to vendor and back again; how everybody winsContains 1 Component(s) Recorded On: 02/07/2018
This presentation will discuss how this ‘overlap’ can be leveraged to produce better products, better interaction and better results for all parties. This presentation will explore opportunities to further these aims and bring the supplier and user of everyday laboratory equipment together.
Large scale profiling in human primary-cell based phenotypic assays identifies novel outcome pathways for drug efficacy in cardiovascular diseaseContains 1 Component(s) Recorded On: 02/07/2018
Findings support the value of a large chemical biology database of reference drugs profiled through primary human cell-based phenotypic assays. This database has been mined to reveal several novel associations with adverse events and identified potential mechanisms of toxicity, and here we show how this database can be used to generate new hypotheses for drug efficacy.
HIPStA, a High Throughput Alternative to CETSAContains 1 Component(s) Recorded On: 02/07/2018
This presentation reviews data demonstrating the proof of concept for the HIPStA method, using 3 different classes of drug discovery targets: Receptor tyrosine kinases, Nuclear Hormone Receptors and Cytoplasmic Protein Kinases. HIPStA represents a more scale-able alternative to CETSA for detecting drug-target interaction in cells.